Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relapse of Crohn's disease: A case report
Flavio Caprioli, Chiara Viganò, Fiorenzo Botti, Ettore Contessini-AvesaniVolume:
4
Year:
2010
Language:
english
DOI:
10.1016/s1594-5804(11)60006-5
File:
PDF, 807 KB
english, 2010